7 assets in Glycogen Storage Disease II

Therapeutic assets addressing Glycogen Storage Disease II, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alglucosidase Alfa Glycogen Storage Disease II	Erasmus Medical Center	P4	A (80)
Avalglucosidase Alfa Glycogen Storage Disease II	Genzyme, a Sanofi Company	P4	A (80)
s-606001 Glycogen Storage Disease II	Shionogi	P2	CCC (53)
Cipaglucosidase Alfa Glycogen Storage Disease II	Amicus Therapeutics	P1/2	CCC (50)
Dna (Recombinant Adeno-Associated Virus Vector Aav-Spark100-Gaa Human Liver-Specific Expression Cassette Including Human Lysosomal ?-Glucosidase Codon-Optimized Gene Gaa Plus Adeno-Associated Virus 2 Inverted Terminal Repeat Flanks) Glycogen Storage Disease II	Spark Therapeutics, Inc.	P1/2	CC (47)
Miglustat Glycogen Storage Disease II	Amicus Therapeutics	P1	CC (43)